Ascentage Pharma CAO reports 12,883 RSUs

Ascentage Pharma Group International reported the initial equity holdings of Chief Accounting Officer Jin Cao.

Accepted by SEC EDGAR 04/10/2026 - 11:50 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Ascentage Pharma Group International reported the initial equity holdings of Chief Accounting Officer Jin Cao. The filing shows 12,883 restricted stock units (RSUs), each representing a contingent right to receive one Ordinary Share upon vesting.

The RSUs vest in four equal installments on November 26 of 2026, 2027, 2028 and 2029 and have no expiration date. The position is held directly and reflects equity-based compensation rather than an open-market share purchase or sale.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Cao Jin

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Holding	Restricted stock units	--	--	--

Holdings: Restricted stock units — 12,883 contracts (Direct)

Footnotes (1)

1. F1. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Key Figures

Restricted stock units: 12,883 units Underlying Ordinary Shares: 12,883 shares Vesting installments: 4 equal tranches +1 more

4 metrics

Restricted stock units 12,883 units RSUs held by Chief Accounting Officer Jin Cao

Underlying Ordinary Shares 12,883 shares Each RSU converts into one Ordinary Share upon vesting

Vesting installments 4 equal tranches Vest on 11/26 of 2026, 2027, 2028 and 2029

Exercise price $0.0000 per unit RSUs representing rights to Ordinary Shares

Key Terms

Restricted stock units, Ordinary Shares, contingent right, vesting

4 terms

Restricted stock units financial

"Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Ordinary Shares financial

"receive one Ordinary Share of the Issuer upon vesting"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

contingent right financial

"represents a contingent right to receive one Ordinary Share"

vesting financial

"The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity position did AAPG’s Chief Accounting Officer report?

AAPG’s Chief Accounting Officer, Jin Cao, reported holding 12,883 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share upon vesting, providing equity-based compensation aligned with future service at Ascentage Pharma Group International.

How do Jin Cao’s AAPG restricted stock units vest over time?

The RSUs vest in four equal increments on November 26 of 2026, 2027, 2028 and 2029. This creates a multi-year vesting schedule that encourages ongoing employment and aligns compensation with long-term company performance.

What does each AAPG restricted stock unit represent for Jin Cao?

Each RSU reported by Jin Cao represents a contingent right to receive one Ordinary Share of Ascentage Pharma Group International. Shares are delivered only upon vesting, meaning the economic benefit depends on continued service through each vesting date.

Do Jin Cao’s AAPG restricted stock units have an expiration date?

The RSUs held by Jin Cao have no expiration date. Instead of expiring, they follow a defined vesting schedule on specific future dates, after which each vested RSU converts into one Ordinary Share of Ascentage Pharma Group International.

Are Jin Cao’s AAPG restricted stock units held directly or indirectly?

The filing shows Jin Cao’s 12,883 restricted stock units as directly owned. Direct ownership means the equity award is attributed personally, rather than being held through a trust, family partnership, or other indirect investment vehicle.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cao Jin

(Last) (First) (Middle)

700 KING FARM BOULEVARD

SUITE 510

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted stock units	(1)	(1)	Ordinary Shares	12,883	$0	D

Explanation of Responses:

1. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Remarks:

	Thomas J. Knapp	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)